BioRestorative Therapies Activates Northwell Health for Phase 2 Clinical Trial on Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc., a clinical-stage company specializing in stem cell-based therapies, has announced the activation of Northwell Health, the largest healthcare provider in New York State, for its ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (cLDD). This activation permits patients in New York to participate in the BRTX-100 trial. The collaboration between […]
Neuroplast Completes Phase II Clinical Trial Inclusion for Traumatic Spinal Cord Injury
Neuroplast, a Dutch clinical-stage biotech company, has successfully concluded the patient inclusion for its Phase II clinical trial, focusing on Traumatic Spinal Cord Injury (TSCI). Here are the key details: Thought-Provoking Questions/Insights: Original Press Release
Excision BioTherapeutics’ Groundbreaking Gene Therapy for HIV: A Closer Look
Excision BioTherapeutics, a clinical-stage biotechnology company, has recently made headlines with its announcement regarding the publication of pre-clinical data supporting its innovative CRISPR-based gene therapy candidate, EBT-101. This therapy is designed to functionally cure HIV-1. Here’s a detailed summary of the press release: Key Findings: CEO’s Statement: Daniel Dornbusch, the Chief Executive Officer of Excision, […]
Unlocking Burn Healing: Aegle’s Breakthrough Therapy
Aegle Therapeutics Corp., a clinical-stage biotechnology company, has announced the initiation of its Phase 1/2a clinical trial, marking the dosing of its first patient. The trial will focus on the administration of AGLE-102™, a novel therapy designed to treat severe second-degree burns. AGLE-102™ is an investigational product made up of native extracellular vesicles, which are […]
2023’s Inventor: Dr. Laurencin’s Regenerative Breakthrough
The Intellectual Property Owners Education Foundation (IPOEF) has honored Dr. Cato T. Laurencin with the esteemed title of “Inventor of the Year” for 2023. This recognition is attributed to Dr. Laurencin’s revolutionary advancements in the field of regenerative engineering. His pioneering work has paved the way for clinical systems that facilitate the healing and regeneration […]
Caring Cross Unveils Affordable Genetic Therapy Strategies
New press release announces the role of Caring Cross, a non-profit organization, in a newly published white paper from the Innovative Genomics Institute, titled “Making Genetic Therapies Affordable and Accessible.” The white paper is the result of yearlong research and focuses on strategies to increase the affordability and accessibility of genetic therapies, including CAR-T technology […]
$32.3M Boost: City of Hope’s Groundbreaking Therapies
City of Hope, a prominent cancer research and treatment organization in the United States, has received a grant of $32.3 million from the California Institute for Regenerative Medicine (CIRM). Funding Allocation The funds will be used to support three novel Phase 1 clinical trials that focus on innovative cell and gene therapy treatments for patients […]
AvenCell’s AVC-201: A New Era in Leukemia Therapy
AvenCell Therapeutics, a leading clinical-stage cell therapy company, has announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (CTA) for AVC-201. AVC-201 is a novel allogeneic CD123-directed switchable CAR-T investigational therapy for the treatment of relapsed/refractory Acute Myeloid Leukemia (AML) and other CD123 positive hematological malignancies. This therapy is the world’s […]
Revolutionary Placental Biomaterials Transform Cell Therapy
Celularity Inc., a biotechnology company specializing in placental-derived allogeneic cell therapies and biomaterial products, has announced that it will present data on its proprietary extracellular matrices (ECM) at the International Conference on Biomaterials Science and Tissue Engineering (ICBSTE), taking place from July 24-26 in Osaka, Japan. The data includes benchtop and clinical case studies for […]
Unlocking Stem Cells: Revolution in Regenerative Medicine with Dr. Melihcan Sezgic
The video above is a presentation by Dr. Melih Can Sezgic at the Regenerative Medicine Symposium, where he discusses the role of stem cells in regenerative medicine, particularly in the fields of plastic, reconstructive, and aesthetic surgery. Here’s a detailed summary of the key points: Please note that this is a summary of a complex […]